CASI - CASI Pharmaceuticals Inc
Previous close
6.54
0 0%
Share volume: 3,853
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$6.54
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | |
| Report Date | 2022-05-12 | 2022-08-12 | 2022-11-14 | 2023-04-26 | |
| Cash flow financing | -3.000 M | 1.001 M | 1.999 M | -3.267 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -4.238 M | -9.483 M | -6.524 M | -843.000 K | |
| Net income | -8.596 M | -7.680 M | -5.201 M | -19.537 M | |
| Depreciation | 433.000 K | 334.000 K | 765.000 K | 890.000 K | |
| Changes in inventories | 3.721 M | 5.791 M | 5.773 M | 6.138 M | |
| Changes in receivables | 10.086 M | 10.260 M | 12.560 M | 12.973 M | |
| Investing Cashflow | -2.288 M | -961.000 K | 16.454 M | 17.954 M | |
| Net Borrowings | -38.888 M | -25.232 M | -31.779 M | -54.312 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -2.288 M | 569.000 K | -467.000 K | -3.426 M | |
| Cash Change | 37.484 M | 18.862 M | 26.742 M | 48.574 M |